Conference abstractPublished 2019
Change of the 2008/16 WHO into 2018 clinical, laboratory, molecular and pathobiological (WHO-CLMP) criteria for diagnosis of the meloproliferative neoplasms JAK2V617F trilinear polycythemia vera (PV), JAK2 exon 12 PV and JAK2V617F, CALR or MPL515 mutated thrombocythemias and secondary myelofibrosis
Subjects
Oncology & CancerConferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Medical Oncology and Therapeutics
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Jan Jacques Michiels”
